Effect of zinc supplementation on bovine luteal function: In vivo and in vitro findings

Alejandro Maruri1, Juan Patricio Anchordoquy2, Nicolás Agustín Farnetano2

  • 1Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de Investigación y Tecnología en Reproducción Animal (INITRA), Av. Chorroarín 280, C1427CWO, CABA, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.

Theriogenology
|March 2, 2025
PubMed

Zinc (Zn) is an essential trace element for cellular processes such as oxidative stress regulation. Research on the relationship between Zn and the corpus luteum (CL) is limited, showing contradictory findings. Zinc supplementation before artificial insemination (AI) increases bovine CL size and progesterone (P4) levels. In mice, in vitro experiments suggest that Zn may reduce P4 production. This study aimed to evaluate the role of Zn in bovine luteal cell function by assessing 1) the effect of parenteral Zn supplementation (400 mg) 7 days after AI on CL size and plasma P4 levels in vivo, and 2) the impact of Zn supplementation (0, 0.8 and 1.2 μg/ml) on P4 production, reactive oxygen species (ROS) levels and luteal cell viability in vitro. In vivo, Zn supplementation increased CL size but reduced plasma P4 levels. In vitro, 0.8 μg/ml Zn decreased P4 synthesis and ROS levels while enhancing cell viability, whereas 1.2 μg/ml Zn had no significant effect compared to the control. These findings indicate that Zn modulates luteal function in a dose-dependent manner, reducing oxidative stress while impairing P4 production. Further studies are needed to optimize Zn supplementation strategies during assisted reproductive technologies and clarify Zn mechanisms of action.

Related Concept Videos

Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Bile01:19

Bile

Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...